SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (45376)2/2/1999 1:03:00 AM
From: Bonnie Bear  Respond to of 132070
 
sniff, sniff...I smell bear in that article....sniff....
sure smells like bear to me.....gawd it smells good....



To: Thomas M. who wrote (45376)2/2/1999 2:27:00 AM
From: Peter Singleton  Read Replies (2) | Respond to of 132070
 
<<"Drug companies have figured out a way to hide their research and
development costs. The big question is whether this gimmickry fools
anybody.">>

ooohhh ... what a dumb, dumb thing these R&D spinouts are, no accounting logic whatsoever. This is gonna hurt a few companies ...

Why did the SEC let things get so out of hand? And, much, much, much worse with ESOPs.

Peter



To: Thomas M. who wrote (45376)2/2/1999 10:06:00 AM
From: Knighty Tin  Read Replies (1) | Respond to of 132070
 
Tom, good article, but we see how dumb investors really are every day. This ruling could impact GENZL and GZTC.

MB



To: Thomas M. who wrote (45376)2/2/1999 2:17:00 PM
From: Earlie  Respond to of 132070
 
Thomas:
A good article. The practice has even been migrated up here. (Biochem has copied it). (g)

Best, Earlie


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News